Page last updated: 2024-10-25

dequalinium and B-Cell Chronic Lymphocytic Leukemia

dequalinium has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies

Dequalinium: A topical bacteriostat that is available as various salts. It is used in wound dressings and mouth infections and may also have antifungal action, but may cause skin ulceration.
dequalinium : A quinolinium ion comprising decane in which one methyl hydrogen at each end of the molecule has been replaced by a 4-amino-2-methylquinolin-1-yl group.

Research Excerpts

ExcerptRelevanceReference
"Dequalinium (DQA) is an antitumoral agent that selectively accumulates in the mitochondria and has been shown to display anticancer activity in cells from different malignancies."1.37Dequalinium induces apoptosis in peripheral blood mononuclear cells isolated from human chronic lymphocytic leukemia. ( Boyano-Adánez, Mdel C; Calviño, E; Diez, JC; Gil, J; Pajuelo, L; Sancho, P, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pajuelo, L1
Calviño, E1
Diez, JC1
Boyano-Adánez, Mdel C1
Gil, J1
Sancho, P1

Other Studies

1 other study available for dequalinium and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Dequalinium induces apoptosis in peripheral blood mononuclear cells isolated from human chronic lymphocytic leukemia.
    Investigational new drugs, 2011, Volume: 29, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Cell Survival; Dequalinium; Humans; In Vitro Techniques; Leukemia,

2011